This webinar on June 5th reviewed effective strategies for cancer immunotherapy administration by providing a glance at IO access across the United States, the United Kingdom, and Nigeria. It featured presentations on different models of access, the challenges related to increasing access to...
The vision of personalized medicine based on tumor-specific biomarkers comes closer to reality with each new scientific discovery. With the advent of AI, researchers now have a novel and expansive tool that can better analyze large-scale data sets for actionable markers that can fuel...
AI is being investigated for real-time monitoring of patients receiving immunotherapy for immune-related adverse events (irAE). Earlier and more accurate detection of toxicities can vastly improve patient outcomes. The first webinar in our series on May 2nd educated participants on the current...
The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC's first educational program crafted specifically for international audiences, titled " Increasing Access to IO: A Global Webinar Series ". This series will...
SITC and ACCC have collaborated on a new webinar aimed at providing further details on the Expanding Access to Cellular and Bispecific Therapy Workshop. This webinar featured expert speakers that provided perspective and thoughts on how to further access to these therapies in the community...
SITC and the National Cancer Institute (NCI) are pleased to launch their fourth "SITC-NCI Computational Immuno-oncology Webinar Series" throughout May-December 2024. This year's series will focus specifically on the application of artificial intelligence (AI) across the field of immuno-oncology ...
Advances in Cancer Immunotherapy™ is a CME- and CE-certified program for clinical oncologists, registered nurses, pharmacists and others involved in treating cancer patients with immunotherapy to learn basic immunology principles and the mechanisms and clinical applications of immunotherapy. ...
On Wednesday, January 26, 2022 from 2 – 3 p.m. ET, join leading experts from the SITC Head and Neck Squamous Cell Carcinoma (HNSCC) Immunotherapy Guideline Expert Panel for "Case Studies in Immunotherapy for the Treatment of HNSCC - SITC CPG Webinar." This high-level webinar will include case...
01-26-2022 | 14:00 - 15:00 ET
On Thursday, January 13, 2022, 12:30-1:30 p.m. EST , join leading experts from the SITC Head and Neck Squamous Cell Carcinoma (HNSCC) Immunotherapy Guideline Expert Panel for "Practical Management Pearls for Immunotherapy for the Treatment of HNSCC – SITC CPG Webinar." This high-level webinar is...
01-13-2022 | 12:30 - 13:30 ET
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us